LGR5 promotes the proliferation of colorectal cancer cells via the Wnt/β-catenin signaling pathway

Oncology Letters

Volumn 9, Issue 6, 2015, Pages 2859-2863

  Lin, Yu ^a,b   Wu, Tingyu ^a   Yao, Qianqian ^a   Zi, Shuming ^a   Cui, Long ^a,c   Yang, Ming ^a   Li, Jinming ^a,c  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colorectal cancer; Leucine rich repeat containing G protein coupled receptor 5; Small interfering RNA; Wnt catenin signaling

Indexed keywords

BETA CATENIN; G PROTEIN COUPLED RECEPTOR; LGR5 RECEPTOR; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; GENE SILENCING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84929993994     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.3144     Document Type: Article

References (38)

1. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet 375: 1030-1047, 2010.
2. Weitz J, Koch M, Debus J, Höhler T, Galle PR and Büchler MW: Colorectal cancer. Lancet 365: 153-165, 2005.
3. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
4. Odoux C, Fohrer H, Hoppo T, et al: A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res 68: 6932-6941, 2008.
5. Wu XS, Xi HQ, Chen L: Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World J Surg Oncol 10: 244, 2012.
6. Lobo NA, Shimono Y, Qian D and Clarke MF: The biology of cancer stem cells. Annu Rev Cell Dev Biol 23: 675-699, 2007.
7. Barker N, van Es JH Kuipers J, et al: Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007, 2007.
8. Barker N, Ridgway RA, van Es JH, et al: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611, 2009.
9. McDonald T, Wang R, Bailey W, et al: Identification and cloning of an orphan G protein-coupled receptor of the glycoprotein hormone receptor subfamily. Biochem Biophys Res Commun 247: 266-270, 1998.
10. Hsu SY, Liang SG and Hsueh AJ: Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Mol Endocrinol 12: 1830-1845, 1998.
11. Van der Flier LG, Sabates-Bellver J, Oving I, et al: The intestinal Wnt/TCF signature. Gastroenterology 132: 628-632, 2007.
12. Carmon KS, Gong X, Lin Q, et al: R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci USA 108: 11452-11457, 2011.
13. de Lau W, Barker N, Low TY, et al: Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476: 293-297, 2011.
14. Early DS, Fontana L and Davidson NO: Translational approaches to addressing complex genetic pathways in colorectal cancer. Transl Res 151: 10-16, 2008.
15. MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms and diseases. Dev Cell 17: 9-26, 2009.
16. Cadigan KM and Peifer M: Wnt signaling from development to disease: Insights from model systems. Cold Spring Harb Perspect Biol 1: a002881, 2009.
17. Schneikert J and Behrens J: The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56: 417-425, 2007.
18. Clevers H and Nusse R: Wnt/β-catenin signaling and disease. Cell 149: 1192-1205, 2012.
19. Metcalfe C and Bienz M: Inhibition of GSK3 by Wnt signalling -two contrasting models. J Cell Sci 124: 3537-3544, 2011.
20. Brabletz T, Hlubek F, Spaderna S, et al: Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal: Epithelial transition, stem cells and β-catenin. Cells Tissues Organs 179: 56-65, 2005.
21. Morin PJ and Weeraratna AT: Wnt signaling in human cancer. Cancer Treat Res 115: 169-187, 2003.
22. Taketo MM: Shutting down Wnt signal-activated cancer. Nat Genet 36: 320-322, 2004.
23. Yamamoto Y, Sakamoto M, Fujii G, et al: Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations. Hepatology 37: 528-533, 2003.
24. McClanahan T, Koseoglu S, Smith K, et al: Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biol Ther 5: 419-426, 2006.
25. Carmon KS, Lin Q, Gong X, et al: LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/β-catenin signaling. Mol Cell Biol 32: 2054-2064, 2012.
26. Al-Kharusi MR, Smartt HJ, Greenhough A, et al: LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: Implications for targeting adenoma stem cells with NSAIDs. Carcinogenesis 34: 1150-1157, 2013.
27. Garcia MI, Ghiani M, Lefort A, et al: LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth cell differentiation in the fetal intestine. Dev Biol 331: 58-67, 2009.
28. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
29. Uchida H, Yamazaki K, Fukuma M, et al: Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci 101: 1731-1737, 2010.
30. Takahashi H, Ishii H, Nishida N, et al: Significance of Lgr5(+ve) cancer stem cells in the colon and rectum. Ann Surg Oncol 18: 1166-1174, 2011.
31. Yang M, Zhong WW, Srivastava N: G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway. Proc Natl Acad Sci USA 102: 6027-6032, 2005.
32. Hsu HC, Liu YS, Tseng KC, et al: Overexpression of Lgr5 correlates with resistance to 5-FU-based chemotherapy in colorectal cancer. Int J Colorectal Dis 28: 1535-1546, 2013.
33. Hirsch D, Barker N, McNeil N, et al: LGR5 positivity defines stem-like cells in colorectal cancer. Carcinogenesis 35: 849-858, 2014.
34. Walker F, Zhang HH, Odorizzi A and Burgess AW: LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PLoS One 6: e22733, 2011
35. Tanese K, Fukuma M, Yamada T, et al: G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. Am J Pathol 173: 835-843, 2008.
36. Fan XS, Wu HY, Yu HP, et al: Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. Int J Colorectal Dis 25: 583-590, 2010.
37. Scannell CA, Pedersen EA, Mosher JT, et al: LGR5 is expressed by Ewing sarcoma and potentiates Wnt/β-catenin signaling. Front Oncol 3: 81, 2013.
38. Wang D, Zhou J, Fan C, et al: Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo. Oncol Rep 31: 41-49, 2014.